XML 24 R52.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:        
Net loss $ (13,036) $ (6,348) $ (57,342) $ (183,189)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization     38,764 48,031
Asset impairments and non-cash restructuring costs     13,602 40,190
Interest expense related to amortization of debt issue costs and debt discount 6,800 2,600 12,687 17,111
Stock-based compensation     1,379 2,984
Deferred income taxes     82 143
Net loss (gain) of unconsolidated joint ventures     6,069 (4,155)
Net gain on disposition of property, plant and equipment     (902) (304)
Gain on convertible debt repayments     (2,350) 0
Decrease (increase) in trade receivables     (1,190) 1,235
Decrease in inventories     2,983 1,490
Increase (decrease) in accounts payable and accrued liabilities     (5,658) (474)
Other changes in operating assets and liabilities, net     3,850 (10,034)
Net cash provided by (used in) operating activities     11,974 (86,972)
Cash flows from investing activities:        
Purchase of property, plant and equipment and payments for acquisitions (7,373) (5,179) (19,205) (19,788)
Proceeds from disposition of property, plant and equipment     1,336 420
Proceeds from sale of interests in joint ventures     18,522 0
Net decrease (increase) in long-term receivables and deposits     (99) 510
Net change in other assets     (875) (1,089)
Net cash used in investing activities     (321) (19,947)
Cash flows from financing activities:        
Net proceeds from issuance of long-term debt     0 392,750
Payments on long-term debt     (32,931) (342,509)
Debt issue costs     (1,040) 0
Employee stock purchases     484 546
Net cash provided by (used in) financing activities     (33,487) 50,787
Net decrease in cash and cash equivalents     (21,834) (56,132)
Cash and cash equivalents, beginning of period     50,810 90,984
Cash and cash equivalents, end of period 28,976 34,852 28,976 34,852
Guarantor Subsidiaries
       
Cash flows from operating activities:        
Net loss 9,457 7,015 9,787 (60,365)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization     38,661 47,959
Asset impairments and non-cash restructuring costs     13,602 39,210
Stock-based compensation     572 1,708
Deferred income taxes     55 (8,826)
Net gain on disposition of property, plant and equipment     (902) (304)
Decrease (increase) in trade receivables     (1,190) 1,235
Decrease in inventories     2,983 1,490
Increase (decrease) in accounts payable and accrued liabilities     (4,739) 7,074
Other changes in operating assets and liabilities, net     (56,656) (12,746)
Net cash provided by (used in) operating activities     2,173 16,435
Cash flows from investing activities:        
Purchase of property, plant and equipment and payments for acquisitions     (18,350) (19,788)
Proceeds from disposition of property, plant and equipment     1,336 420
Net decrease (increase) in long-term receivables and deposits     (2,076) 510
Net change in other assets     (270) (784)
Net cash used in investing activities     (19,360) (19,642)
Cash flows from financing activities:        
Employee stock purchases     349 417
Net cash provided by (used in) financing activities     349 417
Net decrease in cash and cash equivalents     (16,838) (2,790)
Cash and cash equivalents, beginning of period     36,122 21,168
Cash and cash equivalents, end of period 19,284 18,378 19,284 18,378
Non-Guarantor Subsidiaries
       
Cash flows from operating activities:        
Net loss 236 1,723 (6,599) 4,215
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Deferred income taxes     27 174
Net loss (gain) of unconsolidated joint ventures     6,069 (4,155)
Other changes in operating assets and liabilities, net     (18,019) (48)
Net cash provided by (used in) operating activities     (18,522) 186
Cash flows from investing activities:        
Proceeds from sale of interests in joint ventures     18,522  
Net change in other assets       (186)
Net cash used in investing activities     18,522 (186)
Parent Company
       
Cash flows from operating activities:        
Net loss (22,729) (15,086) (60,530) (127,039)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization     103 72
Asset impairments and non-cash restructuring costs       980
Interest expense related to amortization of debt issue costs and debt discount     12,687 17,111
Stock-based compensation     807 1,276
Deferred income taxes       8,795
Gain on convertible debt repayments     (2,350)  
Increase (decrease) in accounts payable and accrued liabilities     (919) (7,548)
Other changes in operating assets and liabilities, net     78,525 2,760
Net cash provided by (used in) operating activities     28,323 (103,593)
Cash flows from investing activities:        
Purchase of property, plant and equipment and payments for acquisitions     (855)  
Net decrease (increase) in long-term receivables and deposits     1,977  
Net change in other assets     (605) (119)
Net cash used in investing activities     517 (119)
Cash flows from financing activities:        
Net proceeds from issuance of long-term debt       392,750
Payments on long-term debt     (32,931) (342,509)
Debt issue costs     (1,040)  
Employee stock purchases     135 129
Net cash provided by (used in) financing activities     (33,836) 50,370
Net decrease in cash and cash equivalents     (4,996) (53,342)
Cash and cash equivalents, beginning of period     14,688 69,816
Cash and cash equivalents, end of period $ 9,692 $ 16,474 $ 9,692 $ 16,474